Oslo is Norway's primary cancer treatment hub. OUS houses the Norwegian Radium Hospital (Radiumhospitalet), the national cancer center providing advanced chemotherapy, radiotherapy, immunotherapy, and surgical oncology. Diakonhjemmet and Lovisenberg Diakonale Sykehus also provide oncology services. The private Kreftklinikken (Tjuvholmen, Oslo) offers private oncology consultations and second opinions.
Public specialist care in Oslo is anchored by Oslo Universitetssykehus (OUS). Patients with GP referrals access subsidized care subject to the national co-payment ceiling. Direct private consultations are centered in Majorstuen, Nationaltheatret, and Aker Brygge.
Accredited specialist practices, hospital outpatient polyclinics (Oslo Universitetssykehus (OUS)), and primary referral centers located directly in Oslo.
Olaf Helsets vei 5, 0694, OSLO
Accredited direct oncologist consultations and diagnostic procedures in Oslo.
Frederik Stangs gate 11, 0264, OSLO
Specialized outpatient hospital department in Oslo evaluating oncologist referrals under Folketrygden.
Frederik Stangs gate 11, 0264, OSLO
Specialized outpatient hospital department in Oslo evaluating oncologist referrals under Folketrygden.
Norwegian GP consultations typically last 15–20 minutes. Select your symptoms and questions below to generate a focused summary you can read, save, or show to your doctor.
OUS Radiumhospitalet (Montebello) is Norway's national cancer hospital treating all major cancer types. It performs specialized procedures including proton therapy, advanced surgical oncology, and CAR-T cell therapy. Urgent cancer referrals are processed under the Pakkeforloep system.
Pakkeforloep for kreft is Norway's structured fast-track cancer diagnostic pathway introduced in 2015. Standardized deadlines apply from the day your GP refers you: typically 28 days from referral to treatment start for most cancer types. In Oslo (Helse Soer-Oest), OUS manages most pathways.
Yes. The Kreftklinikken at Tjuvholmen offers private second opinions for cancer diagnoses and treatment plans. OUS Radiumhospitalet also accepts referrals for second opinions within the public system, particularly for rare or complex cancer cases.
Cancer medications approved for Blaa resept funding are covered by Helfo with no out-of-pocket cost. New drugs go through the national Nye Metoder evaluation before Helfo funding is approved. Patients can check the current Blaa resept drug list on helfo.no.
